Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1399 (21 June), doi:10.1136/bmj.326.7403.1399-a
| The first 150 words of the full text of this article appear below. |
EDITORLabonte and Spiegel in their article have highlighted the need for recognising priorities in health research, the commitments by the rich G8 group, and the emerging new programmes for the control and prevention of disease.1 Clearly, these have strong influences and impacts on global health. It is however, of paramount importance to understand to what level these efforts have been translated into action.
Over 12 years ago, the International Commission on Health Research and Development recommended to the (developing) countries and the international development agencies to invest in essential national health research and in building sustainable research capacities. Since then, several other agencies and forums have been reiterating the same. Unfortunately, few have heeded this call, and evidence shows that investments in health research are still paltry, sadly, more so where the need is acute.
The national processes of setting priorities for health research should be
coupled with
Mohammad Abdur Rab, regional adviser, research policy and cooperation
WHO/EMRO, A R AL Sanhouri Street, PO Box 7608, Cairo 11371, Egypt abdurrabm@emro.who.int